CFLT vs IRD · rev $963.6M vs rev $11.0M
Confluent Inc (CFLT) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CFLT currently screens at market cap $11.13B. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CFLT and IRD stock pages for the full models.
Not investment advice.